Quantcast
HomeSearch

pharma - search results

If you're not happy with the results, please do another search.

As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger

Headline Health -
Common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics are troubling infectious disease specialists.

Crony Capitalists Cash In On Deep State/Big Pharma Revolving Door

Headline Health -
HEADLINE HEALTH – The free flow of key personnel between US regulatory agencies and the corporations they oversee is well known. These personnel often hold...

Which Companies Aren’t Exiting Russia? Big Pharma

Headline Health -
Even as the war in Ukraine has prompted an exodus of international companies from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

Big Pharma’s Chokehold On Diabetics Is About To End

Headline Health -
Civica Rx, a non-profit generic drug maker, has announced that it plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval.

Big Pharma Overcharges Men 400% For Prostate Drug Developed At Taxpayer Expense

Headline Health -
LOS ANGELES TIMES – Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon...

Seeking Refills: Aging Pharmacists Leave Drugstores Vacant in Rural America

Headline Health -
Pharmacies were once routinely bequeathed from one generation to the next, but, in interviews with more than a dozen pharmacists, many said the pressure of running an independent drugstore have them pushing their offspring toward other careers.

Big Pharma Fast-Tracks Omicron Vaccines

Headline Health -
The World Health Organization on Friday said the new strain, named omicron, is a “variant of concern” that may pose a higher risk of reinfection than past mutations of the virus. Pfizer and BioNTech said they are investigating omicron, first labeled B.1.1.529, and can adapt their vaccine quickly if needed.

Big Pharma Spikes Medicare Part B Premiums

Headline Health -
WASHINGTON (AP) — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said...

Pharma Campaign Cash Delivered to Key Lawmakers With Surgical Precision

Headline Health -
Kaiser Health News – The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking...

Boosters Mean Billions For Big Pharma

Headline Health -
Boosters will likely be offered broadly in the coming months. That, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna.
123...29Page 1 of 29

Most Popular

Load more

Recent Comments

RESOURCES
Subscribe to Headline Health
Not Receiving Our Emails?
Unsubscribe/Update Email
Privacy Policy
Comment Policy
Terms of Service
Material Connection Disclosure
RSS
Accessibility

CONTACT US
Advertise with Headline Health
Contact Us
Digital Millennium Copyright Act (DMCA)

HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277

THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.

Copyright 2022 HEADLINEHEALTH.COM